Jefferies analyst Michael Yee maintained a Hold rating on Biogen (BIIB – Research Report) today and set a price target of $130.00. The ...

Shares of Biogen Inc. BIIB shed 1.44% to $115.29 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and Dow ...

PENNINGTON, N.J. and QUÉBEC, April 16, 2025 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in ...

TrueScope Ventures TrueScope Ventures Logo "I've been actively working in the blockchain space and watching it mature for a number of years," says Dave Uhryniak, Founding Partner of Truescope ...

Biogen exits biosimilar JV with Samsung, raising $2.3bn News The South Korean firm just agreed to buy Biogen out of their biosimilar joint venture – Samsung Bioepis – for $2.3 billion.

Biogen has offered to buy all the shares in Sage Therapeutics that it doesn't already own, taking control of their novel antidepressant Zurzuvae. The $7.22-per-share deal for 89.8% of Sage is a 30 ...

PENNINGTON, N.J. and QUÉBEC, April 16, 2025 /CNW/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Feldan ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Bank of Japan (BOJ) Governor Kazuo Ueda attends a press conference after the central bank's policy meeting at BOJ headquarters in Tokyo, Japan, March 19, 2025. REUTERS/Manami Yamada/File Photo ...